Introduction {#Sec1}
============

In 1970, Drs. Fudenberg, Good, Hitzig, Kunkel, Roitt, Rosen, Rowe, Seligmann, and Soothill met under the auspices of the World Health Organization to classify the emerging "primary immune deficiencies." This august group focused on understanding whether immunodeficiencies could be categorized as B cell disorders or T cell disorders \[[@CR1], [@CR2]\]. Their initial report identified 16 distinct immunodeficiencies and included the prophetic comment that "the variable immunodeficiency group probably lumps together a series of syndromes.... Included in this group are cases previously classified as 'congenital', non-sex linked or sporadic hypogammaglobulinemia, primary 'dysgammglobulinemia' of both childhood and adult life, and 'acquired' primary hypogammaglobulinemia. It is hoped that careful analysis of such patients.... will result in delineation of several homogeneous syndromes...". Indeed, the emergence of monogenic causes of hypogammaglobulinemia (Table [3](#Tab3){ref-type="table"}) and disorders with variable immunoglobulin abnormalities associated with immune dysregulation (Table [4](#Tab4){ref-type="table"}) have been the groups of immunodeficiencies most transformed by the advent of new technologies. Another group dramatically impacted by resetting of the clinical radar and new techniques has been the set of disorders associated with a limited spectrum of infectious susceptibility. The graphs in Fig. [1](#Fig1){ref-type="fig"} define the transformation of the field over the interval during which next-generation sequencing came to prominence. The tremendous progress, energy, and enthusiasm in the field currently have led to a greater need than ever for a current cataloging of the disorders.Fig. 1Each publication of the World Health Organization and IUIS Primary Immunodeficiencies Committee was reviewed for the number of conditions listed and displayed graphically \[[@CR1]--[@CR19]\]. The rapid increase in the twenty-first century relates to improved awareness and increasing use of sequencing. Assuming 20,000 coding genes in the human genome, inborn errors of immunity are implicated through mutations in 1.7% of these genes. There are now 330 specific disorders, 320 monogenic defects, 312 distinct genes (nine genes with both LOF and GOF and C4 deficiency requiring defects in both C4A and C4B). **a** The categorization of the inborn errors of immunity according the schema in the current manuscript. **b** The categorization of the inborn errors of immunity according to their inheritance

The new disorders (since 2015 \[[@CR3]\]) represent an impressive spectrum of phenotypes. There are 354 distinct disorders with 344 different gene defects listed. The emerging dominance of next-generation sequencing has driven the rapid increase in the number of recognized disorders which has led to two major consequences. Often new inborn errors of immunity are initially described in a single kindred or a small number of kindreds. This may lead to incorrect assumptions about prevalence and phenotype. In fact, for most disorders, we have little idea of the prevalence within even the recognized population with the described phenotype. The second consequence of the rapid rise of next-generation sequencing is a striking expansion of the phenotypic spectrum associated with many diseases. Where once the phenotype of a given disorder was clear, the spectrum of manifestations often extends impressively once the ascertainment is not linked to a preconceived idea \[[@CR20]\]. As a community, we recognize the importance of publishing cases and small series and to report specific mutations with clinical findings because publications are used to define likelihood of causality during bioinformatic analysis of next-generation sequencing results.

In 1999, the Committee on Primary Immunodeficiencies came under the auspices of the International Union of Immunological Societies (IUIS). The current committee met on February 23--24, 2017, in London to update the classification of human primary immunodeficiencies. Inclusion in this "master list" requires a body of literature supporting causality of a gene defect and a penetrance indicating clinical relevance \[[@CR21]\]. Committee members vote on inclusion of each new disorder and this publications lists those included as of the February 2017 meeting. The landscape is changing so rapidly, and the number of primary immunodeficiencies growing so fast, that two major changes have been implemented. The published list will continue to serve as a reference; however, this list will now be available as a csv file on the IUIS website to enable sorting according to gene, disease name, or clinical/laboratory feature. This file will also include the associated ICD10 codes in order to promote harmonization of utilization. The second major change is to the nomenclature. The term primary immunodeficiency has an important legacy---the abbreviations PID or PIDD are often used by patient organizations and are recognized around the world. However, this terminology does limit the conceptualization of disorders to those in which susceptibility to infection is the main manifestation. The improving recognition of *immune dysregulation* diseases, including the growing field of autoinflammatory disorders and interferonopathies, has mandated that a more encompassing terminology be used. This manuscript, therefore, utilizes "inborn errors of immunity" as the descriptor for the work and the categorization. In addition to embracing technology to remain updated, the companion publication "Update of the Phenotypical IUIS Classification for Primary Immunodeficiencies" will provide a phenotype-oriented approach to the IUIS categorization of disorders. Moreover, a new free application can be found as "PID phenotypical diagnosis" or "PID classification" from iTunes and Android app stores \[[@CR22], [@CR23]\]. Information that is readily accessible is the new standard, and the IUIS Expert Committee on Primary Immunodeficiencies believes that improved access to information will positively impact patient care around the world.

The tables divide disease categories according to common phenotypes for ease of review and searching. Table [1](#Tab1){ref-type="table"} lists combined immunodeficiencies, Table [2](#Tab2){ref-type="table"} lists combined immunodeficiencies with syndromic features, Table [3](#Tab3){ref-type="table"} lists predominantly antibody deficiencies, Table [4](#Tab4){ref-type="table"} lists diseases of immune dysregulation, Table [5](#Tab5){ref-type="table"} lists defects of phagocyte number or function, Table [6](#Tab6){ref-type="table"} lists defects in intrinsic and innate immunity, Table [7](#Tab7){ref-type="table"} lists autoinflammatory diseases, Table [8](#Tab8){ref-type="table"} lists complement deficiencies, and Table [9](#Tab9){ref-type="table"} lists phenocopies of inborn errors of immunity. The division into phenotypes for the purpose of this list does not imply that the presentation is homogeneous. Each disorder is listed only once for the sake of simplicity although distinct modes of inheritance can be listed separately. There are nine genes for which both loss-of-function and gain-of-function variants have been identified: *CFB*, *C3*, *CARD11*, *STAT1*, *STAT3*, *WAS*, *JAK1*, *IFIH1*, and *ZAP70*. For these, the loss-of-function and gain-of-function aspects are listed. Within each table, there are additional sub-tables that segregate into coherent phenotypic sets. At the end of each table, the new disorders, added for this publication, are listed for easy reference. Other features important for navigation of the list include the use of OMIM links \[[@CR24]\]. For additional information on a gene, the links can be accessed from within the online publication. For the second time, we also include non-inborn errors of immunity in Table [9](#Tab9){ref-type="table"}, representing phenocopies of inborn errors which might be important to consider diagnostically.Table 1Immunodeficiencies affecting cellular and humoral immunityDiseaseGenetic defectInheritanceOMIMT cellsB cellsIgAssociated features1. T-B+ severe combined immune deficiency (SCID) γc deficiency (common gamma chain SCID, CD132 deficiency)*IL2RG*XL308380Very lowNormal to highLowLow NK JAK3 deficiency*JAK3*AR600173Very lowNormal to highLowLow NK IL7Rα deficiency*IL7R*AR146661Very lowNormal to highLowNl NK CD45 deficiency*PTPRC*AR151460Very lowNormalLowNl γ/δ Τ cells CD3δ deficiency*CD3D*AR186790Very lowNormalLowNl NK, no γ/δ T cells CD3ε deficiency*CD3E*AR186830Very lowNormalLowNl NK, no γ/δ T cells CD3ζ deficiency*CD247*AR186780Very lowNormalLowNl NK, no γ/δ T cells Coronin-1A deficiency*CORO1A*AR605000Very lowNormalLowDetectable thymus, EBV LAT deficiency*LAT*AR602354Nl to low numberNl to lowHighAdenopathy, splenomegaly, recurrent infections, autoimmunity2. T-B- SCID RAG1 deficiency*RAG1*AR179615Very lowVery lowDecreasedNl NK RAG2 deficiency*RAG2*AR179616Very lowVery lowDecreasedNl NK DCLRE1C (Artemis) deficiency*DCLRE1C*AR605988Very lowVery lowDecreasedNl NK, radiation sensitive DNA PKcs deficiency*PRKDC*AR176977Very lowVery lowVariableNl NK, radiation sensitive, microcephaly Cernunnos/XLF deficiency*NHEJ1*AR611290Very lowVery lowDecreasedNl NK, radiation sensitive, microcephaly DNA ligase IV deficiency*LIG4*AR601837Very lowVery lowDecreasedNl NK, radiation sensitive, microcephaly Reticular dysgenesis*AK2*AR103020Very lowNl to lowDecreasedGranulocytopenia and deafness Adenosine deaminase (ADA) deficiency*ADA*AR608958Very lowLow, decreasingLow, decreasingLow NK, bone defects, may have pulmonary alveolar proteinosis, cognitive defects3. Combined immunodeficiencies generally less profound than severe combined immunodeficiency DOCK2 deficiency*DOCK2*AR603122LowNormalIgG Nl or low, poor antibody responsesNl NK cells, but defective function. Poor interferon responses in hematopoietic and non-hematopoietic cells CD40 ligand deficiency (CD154)*CD40LG* (*TNFSF5*)XL300386Nl to lowsIgM^+^, IgD^+^ cells present, absent sIgG^+^, IgA^+^, and IgE^+^ cellsIgM normal or high, other Ig isotypes lowNeutropenia, thrombocytopenia, hemolytic anemia, opportunistic infections, biliary tract and liver disease, *Cryptosporidium* infections CD40 deficiency*CD40* (*TNFRSF5*)AR109535NormalsIgM^+^, IgD^+^ cells present, absent sIgG^+^, IgA^+^ and IgE^+^ cellsIgM normal or high, other Ig isotypes lowNeutropenia, opportunistic infections, gastrointestinal and biliary tract and liver disease, *Cryptosporidium* infections ICOS deficiency*ICOS*AR604558NormalNormalLowRecurrent infections, autoimmunity, gastroenteritis, granulomas CD3γ deficiency*CD3G*AR186740Nl number, but low TCR expressionNormalNormal CD8 deficiency*CD8A*AR186910Absent CD8, nl CD4NormalNormalRecurrent infections, may be asymptomatic ZAP-70 deficiency (ZAP70 LOF)*ZAP70*AR176947Low CD8, Nl CD4 number but poor functionNormalNormalMay have immune dysregulation, autoimmunity MHC class I deficiency*TAP1*AR170260Low CD8, Nl CD4, absent MHC I on lymphocytesNormalNormalVasculitis, pyoderma gangrenosum MHC class I deficiency*TAP2*AR170261Low CD8, Nl CD4, absent MHC I on lymphocytesNormalNormalVasculitis, pyoderma gangrenosum MHC class I deficiency*TAPBP*AR601962Low CD8, Nl CD4, absent MHC I on lymphocytesNormalNormalVasculitis, pyoderma gangrenosum MHC class I deficiency*B2M*AR109700Low CD8, Nl CD4, absent MHC I on lymphocytesNormalNormalSinopulmonary infections, cutaneous granulomas. Absent β2m associated proteins MHC I, CD1a, CD1b, CD1c MHC class II deficiency group A*CIITA*AR600005Low CD4 cells\
Absent MHC II expression on lymphocytesNormalNl to lowRespiratory and gastrointestinal infections, liver/biliary tract disease MHC class II deficiency group B*RFXANK*AR603200Low CD4 cells\
Absent MHC II expression on lymphocytesNormalNl to lowRespiratory and gastrointestinal infections, liver/biliary tract disease MHC class II deficiency group C*RFX5*AR601863Low CD4 cells\
Absent MHC II expression on lymphocytesNormalNl to lowRespiratory and gastrointestinal infections, liver/biliary tract disease MHC class II deficiency group D*RFXAP*AR601861Low CD4 cells\
Absent MHC II expression on lymphocytesNormalNl to lowRespiratory and gastrointestinal infections, liver/biliary tract disease DOCK8 deficiency*DOCK8*AR243700Low, poor proliferation, few, poorly functioning TregLow, low CD27+ memory B cells Poor peripheral B cell toleranceLow IgM, Nl to high IgG and IgA, high IgELow NK cells with poor function, eosinophilia, recurrent infections, cutaneous viral, fungal and staphylococcal infections, severe atopy, cancer diathesis Rhoh deficiency*RHOH*AR602037Nl number, low naïve T cells, restricted repertoire, poor proliferation to CD3NormalNormalHPV infection, lung granulomas, molluscum contagiosum, lymphoma MST1 deficiency*STK4*AR614868Low, low terminal differentiated effector memory (TEMRA) cells, low naïve T cells, poor proliferationLowHighIntermittent neutropenia, bacterial, viral (HPV), candidal infections, EBV lymphoproliferation, autoimmune cytopenias, lymphoma, congenital heart disease TCRα deficiency*TRAC*AR615387Absent TCRαβ, all T cells are γδ, poor proliferationNormalNormalRecurrent viral, bacterial, fungal infections, immune dysregulation and autoimmunity, diarrhea LCK deficiency*LCK*AR615758Low CD4^+^, low Treg, restricted T cell repertoire, poor TCR signalingNormalNl IgG and IgA, high IgMRecurrent infections, immune dysregulation, autoimmunity MALT1 deficiency*MALT1*AR615468Nl number, poor proliferationNormalNl levels, poor specific antibody responseBacterial, fungal and viral infections CARD11 deficiency (LOF)*CARD11*AR615206Nl number, predominant naïve T cells, poor proliferationNormal, transitional B cell predominanceAbsent/low*Pneumocystis jirovecii* pneumonia, bacterial and viral infections BCL10 deficiency*BCL10*AR616098Nl number, low memory T and Treg cells, poor antigen and anti-CD3 proliferationNl number, decreased memory and switched B cellsLowRecurrent bacterial and viral infections, candidiasis, gastroenteritis BCL11B deficiency*BCL11B*AD617237Low, poor proliferationNormalNormalCongenital abnormalities, neonatal teeth, dysmorphic facies, absent corpus callosum, neurocognitive deficits IL-21 deficiency*IL21*AR615767Nl number, nl/low functionLowLow IgGSevere early-onset colitis, recurrent sinopulmonary infections IL-21R deficiency*IL21R*AR615207Nl number, low cytokine production, poor antigen proliferationNormalNl number, poor specific antibody responsesRecurrent infections, *Pneumocystis jiroveci*, *Cryptosporidium* infections and liver disease OX40 deficiency*TNFRSF4*AR615593Nl numbers, low antigen specific memory CD4+Nl numbers, low memory B cellsNormalImpaired immunity to HHV8, Kaposi's sarcoma IKBKB deficiency*IKBKB*AR615592Nl number, absent Treg and γ/δ T cells, impaired TCR activationNl number, poor functionLowRecurrent bacterial, viral, fungal infections, opportunistic infections NIK deficiency*MAP3K14*AR604655Nl number, poor proliferation to antigenLow, low switched memory B cellsLow Ig'sLow NK number and function, recurrent bacterial, viral and *Cryptosporidium* infections RelB deficiency*RELB*AR604758Nl number, poor diversity, poor functionRecurrent infections Moesin deficiency*MSN*XL300988Nl number, defective migration, proliferationLow numberLow Ig's over timeRecurrent infections with bacteria, varicella, neutropenia TFRC deficiency*TFRC*AR616740Nl number, poor proliferationNl number, low memory B cellsLowRecurrent infections, neutropenia, thrombocytopeniaSCID/CID spectrum: Infants with SCID who have maternal T cell engraftment may have T cells in normal numbers that do not function normally; these cells may cause autoimmune cytopenias or graft versus host disease. Hypomorphic mutations in several of the genes that cause SCID may result in Omenn syndrome (OS), or "leaky" SCID, or still less profound combined immunodeficiency (CID) phenotypes. Both OS and leaky SCID can be associated with \> 300 autologous T cells/μL of peripheral blood and reduced, rather than absent, proliferative responses when compared with typical SCID caused by null mutations. A spectrum of clinical findings including typical SCID, OS, leaky SCID, CID, granulomas with T lymphopenia, autoimmunity and CD4 T lymphopenia can be found in an allelic series of *RAG1* and other SCID-associated genes. Total number of disorders in Table [1](#Tab1){ref-type="table"}: 49 (17 SCID, 32 CID). New disorders: 5, *MOESIN*, *BCL11B*, *TFRC*, *RELB*, *LAT*. Removed gene: UNC119 deficiency has been removed. The *UNC119* variant reported previously is a benign polymorphism in unaffected individuals*SCID* severe combined immunodeficiency, *EBV* Epstein-Barr virus, *MHC* major histocompatibility complex, *HPV* human papillomavirus, *Treg* T regulatory cell, *Nl* normal, *XL* X-linked inheritance, *AR* autosomal recessive inheritance, *AD* autosomal dominant inheritance, *LOF* loss-of-function Table 2Combined immunodeficiencies with associated or syndromic featuresDiseaseGenetic defectInheritanceOMIMT cellsB cellsIgAssociated features1. Immunodeficiency with congenital thrombocytopenia Wiskott-Aldrich syndrome (WAS LOF)*WAS*XL300392Progressive decrease in numbers, abnormal lymphocyte responses to anti-CD3Normal numbersLow IgM and antibody responses to polysaccharides, often high IgA and IgEThrombocytopenia with small platelets, recurrent bacterial and viral infections, bloody diarrhea, eczema, lymphoma, autoimmune disease, IgA nephropathy, vasculitis. XL thrombocytopenia is a mild form of WAS, and XL neutropenia is caused by missense mutations in the GTPase binding domain of WASp WIP deficiency*WIPF1*AR602357Reduced, defective lymphocyte responses to anti-CD3Normal or lowNormal, except for high IgEThrombocytopenia with or without small platelets, recurrent bacterial and viral infections, eczema, bloody diarrhea, WAS protein absent ARPC1B deficiency*ARPC1B*AR604223NormalNormal numbersNormal except for high IgA and IgEMild thrombocytopenia with normal sized platelets, recurrent invasive infections, colitis, vasculitis, autoantibodies (ANA, ANCA), eosinophilia, defective Arp2/3, filament branching2. DNA repair defects other than those listed in Table [1](#Tab1){ref-type="table"} Ataxia-telangiectasia*ATM*AR607585Progressive decrease, abnormal proliferation to mitogensNormalOften low IgA, IgE and IgG subclasses, increased IgM monomers, antibodies variably decreasedAtaxia, telangiectasia, pulmonary infections, lymphoreticular and other malignancies, increased alpha fetoprotein, increased radiosensitivity, chromosomal instability and chromosomal translocations Nijmegen breakage syndrome*NBS1*AR602667Progressive decreaseVariably reducedOften low IgA, IgE, and IgG subclasses, increased IgM, antibodies variably decreasedMicrocephaly, dysmorphic facies, lymphomas, solid tumors, increased radiosensitivity, chromosomal instability Bloom Syndrome*BLM* (*RECQL3*)AR604610NormalNormalLowShort stature, dysmorphic facies, sun-sensitive erythema, marrow failure, leukemia, lymphoma, chromosomal instability Immunodeficiency with centromeric instability and facial anomalies, ICF1*DNMT3B*AR602900Decreased or normal, responses to PHA may be decreasedDecreased or normalHypogammaglobulinemia or agammaglobulinemia, variable antibody deficiency Immunodeficiency with centromeric instability and facial anomalies, ICF2*ZBTB24*AR614064Decreased or normal,Decreased or normalHypogammaglobulinemia or agammaglobulinemia, variable antibody deficiency Immunodeficiency with centromeric instability and facial anomalies, ICF3*CDCA7*AR609937responses to PHA may be decreasedDecreased or normalHypogammaglobulinemia or agammaglobulinemia, variable antibody deficiency Immunodeficiency with centromeric instability and facial anomalies, ICF4*HELLS*AR603946Decreased or normalDecreased or normalHypogammaglobulinemia or agammaglobulinemia, variable antibody deficiency PMS2 deficiency*PMS2*AR600259NormalLow B cells, switched and non-switchedLow IgG and IgA, high IgM, abnormal antibody responsesRecurrent infections, café-au-lait spots, lymphoma, colorectal carcinoma, brain tumors RNF168 deficiency (radiosensitivity, immune deficiency, dysmorphic features, learning difficulties \[RIDDLE\] syndrome)*RNF168*AR612688NormalNormalLow IgG or IgAShort stature, mild defect of motor control to ataxia, normal intelligence to learning difficulties, mild facial dysmorphism to microcephaly, increased radiosensitivity MCM4 deficiency*MCM4*AR602638NormalNormalNormalNK cells: low number and function. Viral infections (EBV, HSV, VZV), short stature, B cell lymphoma, adrenal failure POLE1 (polymerase ε subunit 1) deficiency (FILS syndrome)*POLE*AR174762Decreased T cell proliferationLow memory B cellsLow IgG2 and IgM, lack of antibody to PPSRecurrent respiratory infections, meningitis, facial dysmorphism, livido, short stature POLE2 (polymerase ε subunit 2) deficiency*POLE2*AR602670Lymphopenia, lack of TRECS, absent proliferation in response to antigensVery lowHypogammaglobulinemiaRecurrent infections, disseminated BCG infections, autoimmunity (type 1 diabetes, hypothyroidism, facial dysmorphism Ligase I deficiency*LIG1*AR126391Lymphopenia, decreased mitogen responseNormalLow IgA and IgG\
Reduced antibody responsesRecurrent respiratory infections, growth retardation, sun sensitivity, lymphoma, radiation sensitivity NSMCE3 deficiency*NSMCE3*AR608243Number decreased, poor response to mitogens and antigensNormalNormal\
Decreased Ab responses to PPS normal IgG, IgA, elevated IgMSevere lung disease (possibly viral), thymic hypoplasia, chromosomal breakage, radiation sensitivity ERCC6L2 (Hebo deficiency)*ERCC6L2*AR615667LymphopeniaLowNormalFacial dysmorphism, microcephaly, bone marrow failure GINS1 deficiency*GINS1*AR610608Low or normalLow or normalHigh IgA, low IgM and IgGNeutropenia, IUGR, NK cells very low3. Thymic defects with additional congenital anomalies DiGeorge/velocardiofacial syndrome\
Chromosome 22q11.2 deletion syndrome (22q11.2DS)*Large deletion* (*3 Mb*) *typically in chromosome 22*AD602054Decreased or normal, 5% have \< 1500 CD3T cells/μL in neonatal periodNormalNormal or decreasedHypoparathyroidism, conotruncal cardiac malformation, velopalatal insufficiency, abnormal facies, intellectual disabilityDiGeorge/velocardiofacial syndromeUnknownSporadicDecreased or normalNormalNormal or decreasedHypoparathyroidism, conotruncal cardiac malformation, velopalatal insufficiency, abnormal facies, intellectual disability TBX1 deficiency*TBX1*AD602054Decreased or normalNormalNormal or decreasedHypoparathyroidism, conotruncal cardiac malformation, velopalatal insufficiency, abnormal facies, intellectual disability CHARGE syndrome due to CHD7 deficiency*CHD7*AD608892Decreased or normal, response to PHA may be decreasedNormalNormal or decreasedColoboma, heart anomaly, choanal atresia, intellectual disability, genital and ear anomalies, CNS malformation, some are SCID-like and have low TRECs CHARGE syndrome due to SEMA3E deficiency*SEMA3E*AD608166Decreased or normal, response to PHA may be decreasedNormalNormal or decreasedColoboma, heart anomaly, choanal atresia, intellectual retardation, genital and ear anomalies, CNS malformation, some are SCID-like and have low TRECs CHARGE syndromeUnknownDecreased or normal, response to PHA may be decreasedNormalNormal or decreasedColoboma, heart anomaly, choanal atresia, intellectual disability, genital and ear anomalies, CNS malformation, some are SCID-like and have low TRECs Winged helix nude FOXN1 deficiency*FOXN1*AR600838Very lowNormalDecreasedSevere infections, abnormal thymic epithelium, immunodeficiency, congenital alopecia, nail dystrophy, neural tube defect Chromosome 10p13-p14 deletion Syndrome (10p13-p14DS)*Del10p13-p14*AD601362Normal, rarely lymphopenia and decreased lymphoproliferation to mitogens and antigens, hypolastic thymus may be presentNormalNormalHypoparathyroidism, renal disease, deafness, growth retardation, facial dysmorphism, cardiac defects may be present, recurrent infections +/−4. Immuno-osseous dysplasias Cartilage hair hypoplasia (CHH)*RMRP*AR157660Varies from severely decreased (SCID) to normal, impaired lymphocyte proliferationNormalNormal or reduced, antibodies variably decreasedShort-limbed dwarfism with metaphyseal dysostosis, sparse hair, bone marrow failure, autoimmunity, susceptibility to lymphoma and other cancers, impaired spermatogenesis, neuronal dysplasia of the intestine Schimke immuno-osseous dysplasia*SMARCAL1*AR606622DecreasedNormalNormalShort stature, spondiloepiphyseal dysplasia, intrauterine growth retardation, nephropathy, bacterial, viral, fungal infections, may present as SCID, bone marrow failure MYSM1 deficiency*MYSM1*AR612176T cell lymphopenia, reduced naïve T cellsImmature B cellsHypogammaglobulinemiaShort stature, recurrent infections, congenital bone marrow failure, myelodysplasia, immunodeficiency affecting B cells and granulocytes, skeletal anomalies, cataracts, developmental delay. MOPD1 deficiency*RNU4ATAC*AR601428NormalNormalNormal, specific antibodies variably decreasedRecurrent bacterial infections, lymphadenopathy, spondyloepiphyseal dysplasia, extreme intrauterine growth retardation, retinal dystrophy, facial dysmorphism, may present with microcephaly EXTL3 deficiency*EXTL3*ARReducedNormalVariably decreasedPlatyspondyly, kyphosis, variable skeletal dysplasias, developmental delay5. Hyper IgE syndromes (HIES) AD-HIES\
STAT3 deficiency\
(Job syndrome)*STAT3*AD LOF102582Normal overall, Th-17 and T-follicular helper cells decreasedNormal, reduced switched and non-switched memory B cells, BAFF expression increasedHigh IgE, specific antibody production decreasedDistinctive facial features (broad nasal bridge), bacterial infections (boils and pulmonary abscesses, pneumatoceles) due to *S. aureus*, pulmonary aspergillus, *Pneumocystis jirovecii*, eczema, mucocutaneous candidiasis, hyperextensible joints, osteoporosis and bone fractures, scoliosis, retention of primary teeth, coronary and cerebral aneurysm formation Comel-Netherton syndrome*SPINK5*AR605010NormalLow Switched and non-switched B cellsHigh IgE and IgA\
Antibody variably decreasedCongenital ichthyosis, bamboo hair, atopic diathesis, increased bacterial infections, failure to thrive PGM3 deficiency*PGM3*AR172100CD8 and CD4 T cells may be decreasedLow B and memory B cellsNormal or elevated IgG and IgA, most high IgE, eosinophiliaSevere atopy, autoimmunity, bacterial and viral infections, skeletal anomalies dysplasia: short stature, brachydactyly, dysmorphic facial features, and intellectual disability cognitive impairment, hypomyelination6. Dyskeratosis congenita (DKC), myelodysplasia, short telomeres XL-DKC due to dyskerin deficiency*DKC1*XL300126Progressive decreaseProgressive decreaseVariable hypogammaglobulinemiaIntrauterine growth retardation, microcephaly, nail dystrophy, sparse scalp hair and eyelashes, hyperpigmentation of skin, palmar hyperkeratosis, premalignant oral leukoplakia, pancytopenia, myelodysplasia, +/− recurrent infections. A severe phenotype with developmental delay and cerebellar hypoplasia known as Hoyeraal-Hreidarsson syndrome (HHS) may occur in some DKC patients AR-DKC due to nucleolar protein family A member 2 (NHP2) deficiency*NHP2*AR606470DecreasedVariableVariable AR-DKC due to nucleolar protein family A member 3 (NHP3) or NOP10 deficiency*NOP10*AR606471DecreasedVariableVariable AD/AR-DKC due to regulator of telomere elongation (RTEL1) deficiency*RTEL1*AD or AR608833DecreasedVariableVariable AD-DKC due to TERC deficiency*TERC*AD602322VariableVariableVariable AD/AR-DKC due to TERT deficiency*TERT*AD or AR187270VariableVariableVariable AD-DKC due to TINF2 deficiency*TINF2*AD604319VariableVariableVariable AD/AR-DKC due to TPP1 deficiency*TPP1*AD or AR609377VariableVariableVariable AR-DKC due to DCLRE1B deficiency*DCLRE1B/SNM1/APOLLO:*AR609683VariableVariableVariable AR-DKC due to PARN deficiency*PARN*AR (AD?)604212VariableVariableVariable AR-DKC due to WRAP53 deficiency*WRAP53*AR612661Not reportedNot reportedNot reported Coats plus syndrome due to STN1 deficiency*STN1*AR613128VariableVariableNot knownIntrauterine growth retardation, premature aging, pancytopenia, hypocellular bone marrow, gastrointestinal hemorrhage due to vascular ectasia, intracranial calcification, abnormal telomeres Coats plus syndrome due to CTC1 deficiency*CTC1*AR613129NormalNormalNormalIntrauterine growth retardation, sparse graying hair, dystrophic nails, trilinear bone marrow failure, osteopenia, gastrointestinal hemorrhage due to vascular ectasia, retinal telangiectasia, intracranial calcification, abnormal telomeres SAMD9*SAMD9*AD (GOF)617053Not reportedNot reportedNot reportedIUGR with gonadal abnormalities, adrenal failure, MDS with chromosome 7 aberrations, predisposition to infections, enteropathy, absent spleen SAMD9L*SAMD9L*AD (GOF)159550NormalLowNot reportedCytopenia, predisposition to MDS with chromosome 7 aberrations, immunodeficiency, and progressive cerebellar dysfunction7. Defects of vitamin B~12~ and folate metabolism Transcobalamin 2 deficiency*TCN2*AR613441NormalVariableDecreasedMegaloblastic anemia, pancytopenia, if untreated for prolonged periods results in intellectual disability SLC46A1/PCFT deficiency causing hereditary folate malabsorption*SLC46A1*AR229050Variable numbers and activation profileVariableDecreasedMegaloblastic anemia, if untreated for prolonged periods results in intellectual disability Methylene-tetrahydrofolate dehydrogenase 1 (MTHFD1) deficiency*MTHFD1*AR172460Low thymic output, normal in vitro proliferationLowDecreased/poor antibody responses to conjugated polysaccharide antigensRecurrent bacterial infection, *Pneumocystis jirovecii*, megaloblastic anemia, neutropenia, seizures, intellectual disability, folate-responsive8. Anhidrotic ectodermodysplasia with immunodeficiency (EDA-ID)) EDA-ID due to NEMO /IKBKG deficiency (ectodermal dysplasia, immune deficiency)*NEMO* (*IKBKG*)XL300248Normal or decreased, TCR activation impairedNormal\
Low memory and isotype switched B cellsDecreased, some with elevated IgA, IgM, poor specific antibody responses, absent antibody to polysaccharide antigensAnhidrotic ectodermal dysplasia (in some), various infections (bacteria, mycobacteria, viruses and fungi), colitis, conical teeth, variable defects of skin, hair and teeth, monocyte dysfunction EDA-ID due to IKBA GOF mutation*IKBA* (*NFKBIA*)AD GOF164008Normal total T cells, TCR activation impairedNormal B cell numbers, impaired BCR activation, low memory and isotype switched B cellsDecreased IgG and IgA, elevated IgM, poor specific antibody responses, absent antibody to polysaccharide antigensAnhidrotic ectodermal dysplasia, various infections (bacteria, mycobacteria, viruses and fungi), colitis, variable defects of skin, hair and teeth, T cell and monocyte dysfunction9. Calcium channel defects ORAI-1 deficiency*ORAI1*AR610277Normal, defective TCR mediated activationNormalNormalAutoimmunity, EDA, non-progressive myopathy STIM1 deficiency*STIM1*AR605921Normal, defective TCR mediated activationNormalNormalAutoimmunity, EDA, non-progressive myopathy10. Other defects Purine nucleoside phosphorylase (PNP) deficiency*PNP*AR164050Progressive decreaseNormalNormal or lowAutoimmune hemolytic anemia, neurological impairment Immunodeficiency with multiple intestinal atresias*TTC7A*AR609332Variable, but sometimes absent low TRECsNormal or lowMarkedly decreased IgG, IgM, IgABacterial (sepsis), fungal, viral infections, multiple intestinal atresias, often with intrauterine polyhydramnios and early demise, some with SCID phenotype Hepatic veno-occlusive disease with immunodeficiency (VODI)*SP110*AR604457Normal (decreased memory T cells)Normal (decreased memory B cells)Decreased IgG, IgA, IgM, absent germinal centers and tissue plasma cellsHepatic veno-occlusive disease, Susceptibility to *Pneumocystis jirovecii* pneumonia, CMV, candida, thrombocytopenia, hepatosplenomegaly, cerebrospinal leukodystrophy Vici syndrome due to EPG5 deficiency*EPG5*AR615068Profound depletion of CD4+ cellsDefectiveDecreased (particularly IgG2)Agenesis of the corpus callosum, cataracts, cardiomyopathy, skin hypopigmentation, intellectual disability, microcephaly, recurrent infections, chronic mucocutaneous candidiasis HOIL1 deficiency*HOIL1* (*RBCK1*)AR610924Normal numbersNormal, decreased memory B cellsPoor antibody responses to polysaccharidesBacterial infections, autoinflammation, amylopectinosis HOIP deficiency*RNF31*AR612487Normal numbersNormal, decreased memory B cellsdecreasedBacterial infections, autoinflammation, amylopectinosis, lymphangiectasia Hennekam-lymphangiectasia-lymphedema syndrome due to CCBE1 deficiency*CCBE1*AR612753Low/variableLow/variabledecreasedLymphangiectasia and lymphedema with facial abnormalities and other dysmorphic features Hennekam-lymphangiectasia-lymphedema syndrome due to FAT4 deficiency*FAT4*AR612411Low/variableLow/variabledecreasedLymphangiectasia and lymphedema with facial abnormalities and other dysmorphic features STAT5b deficiency*STAT5B*AR604260Modestly decreasedNormalNormalGrowth-hormone insensitive dwarfism, dysmorphic features, eczema, lymphocytic interstitial pneumonitis, autoimmunity Kabuki syndrome 1 due to KMT2D deficiency*KMT2D* (*MLL2*)AD602113NormalNormalLow IgA and occasionally low IgGTypical facial abnormalities, cleft or high arched palate, skeletal abnormalities, short stature, intellectual disability, congenital heart defects, recurrent infections (otitis media, pneumonia) in 50% of patients. Autoimmunity may be present Kabuki syndrome 2 due to KDM6A deficiency*KDM6A*XL (females may be affected)300128NormalNormalLow IgA and occasionally IgGPure bone marrow failure syndromes have not been included. Total number of disorders in Table [2](#Tab2){ref-type="table"}: 67. New disorders: 23, *ARPC1B*, *CDCA7*, *HELLS*, *POLE2*, *LIG1*, *GINS1*, *NSMCE3*, *ERCC6L2*, *TBX1*, *MYSM1*, *MOPD1*, *STN1*, *CTC1*, *KMT2D*, *KDM6A*, *SAMD9*, *SAMD9L*, *EXTL3*, *WRAP53*, *FAT4*. Unknown cause of DiGeorge syndrome, unknown cause CHARGE, 10p13-14 deletion*IUGR* intrauterine growth retardation, *HSV* herpes simplex virus, *VZV* varicella zoster virus, *BCG* Bacillus Calmette-Guerin, *XL* X-linked inheritance, *AR* autosomal recessive inheritance, *AD* autosomal dominant inheritance, *LOF* loss-of-function, *GOF* gain-of-function Table 3Predominantly antibody deficienciesDiseaseGenetic defectInheritanceOMIMIgAssociated features1. Severe reduction in all serum immunoglobulin isotypes with profoundly decreased or absent B cells, agammaglobulinemia BTK deficiency, X-linked agammaglobulinemia (XLA)*BTK*XL300300All isotypes decreased in majority of patients, some patients have detectable immunoglobulinsSevere bacterial infections, normal numbers of pro-B cells μ heavy chain deficiency*IGHM*AR147020All isotypes decreasedSevere bacterial infections, normal numbers of pro-B cells λ5 deficiency*IGLL1*AR146770All isotypes decreasedSevere bacterial infections, normal numbers of pro-B cells Igα deficiency*CD79A*AR112205All isotypes decreasedSevere bacterial infections, normal numbers of pro-B cells Igβ deficiency*CD79B*AR147245All isotypes decreasedSevere bacterial infections, normal numbers of pro-B cells BLNK deficiency*BLNK*AR604515All isotypes decreasedSevere bacterial infections, normal numbers of pro-B cells PIK3R1 deficiency*PIK3R1*AR171833All isotypes decreasedSevere bacterial infections, decreased or absent pro-B cells E47 transcription factor deficiency*TCF3*AD147141All isotypes decreasedRecurrent bacterial infections2. Severe reduction in at least 2 serum immunoglobulin isotypes with normal or low number of B cells, CVID phenotype Common variable immune deficiency with no gene defect specified (CVID)*Unknown*VariableLow IgG and IgA and/or IgMClinical phenotypes vary: most have recurrent infections, some have polyclonal lymphoproliferation, autoimmune cytopenias and/or granulomatous disease PIK3CD mutation (GOF)*PIK3CD GOF*AD602839All isotypes decreasedSevere bacterial infections; decreased or absent pro-B cells, EBV PIK3R1 deficiency (LOF)*PIK3R1*AD616005All isotypes decreasedSevere bacterial infections, pro-B cells present and low numbers of memory B cells, EBV PTEN Deficiency (LOF)*PTEN*AD601728DecreasedLymphoproliferation, autoimmunity CD19 deficiency*CD19*AR107265Low IgG and IgA and/or IgMRecurrent infections, may have glomerulonephritis CD81 deficiency*CD81*AR186845Low IgG, low or normal IgA and IgMRecurrent infections, may have glomerulonephritis CD20 deficiency*MS4A1*AR112210Low IgG, normal or elevated IgM and IgARecurrent infections CD21 deficiency*CR2*AR120650Low IgG, impaired anti-pneumococcal responseRecurrent infections TACI deficiency*TNFRSF13B* (*TACI*)AD or AR604907Low IgG and IgA and/or IgMVariable clinical expression BAFF receptor deficiency*TNFRSF13C* (*BAFF-R*)AR606269Low IgG and IgM,Variable clinical expression TWEAK deficiency*TNFSF12*AD602695Low IgM and A, lack of anti-pneumococcal antibodyPneumonia, bacterial infections, warts, thrombocytopenia. Neutropenia Mannosyl-oligosaccharide glucosidase deficiency (MOGS)*MOGS* (*GCS1*)AR601336Severe hypogammaglobulinemia,Bacterial and viral infections, severe neurologic disease, also known as congenital disorder of glycosylation type IIb (CDG-IIb) TRNT1 deficiency*TRNT1*AR612907B cell deficiency and hypogammaglobulinemiaCongenital sideroblastic anemia, deafness, developmental delay TTC37 deficiency*TTC37*AR614649Poor antibody response to pneumococcal vaccineRecurrent bacterial and viral infections, abnormal hair findings: trichorrhexis nodosa NFKB1 deficiency*NFKB1*AD164011Normal or low IgG, IgA, IgM, low or normal B cells, low memory B cellsRecurrent sinopulmonary infections, COPD, EBV proliferation, autoimmune cytopenias, alopecia and autoimmune thyroiditis NFKB2 deficiency*NFKB2*AD615577Low serum IgG, A and M; low B cell numbersRecurrent sinopulmonary infections, alopecia, and endorinopathies IKAROS deficiency*IKZF1*AD603023Low IgG, IgA, IgM, low or normal B cells, potentially reducing levels with ageRecurrent sinopulmonary infections IRF2BP2 deficiency*IRF2BP2*AD615332Hypogammaglobulenia, absent IgARecurrent infections, possible autoimmunity and inflammatory disease ATP6AP1 deficiency*ATP6AP1*XL300197Variable immunoglobulin findingsHepatopathy, leukopenia, low copper3. Severe reduction in serum IgG and IgA with normal/elevated IgM and normal numbers of B cells, hyper IgM AID deficiency*AICDA*AR605257IgG and IgA decreased, IgM increasedBacterial infections, enlarged lymph nodes and germinal centers UNG deficiency*UNG*AR191525IgG and IgA decreased, IgM increasedEnlarged lymph nodes and germinal centers INO80*INO80*AR610169IgG and IgA decreased, IgM increasedSevere bacterial infections MSH6*MSH6*AR600678Variable IgG, defects, increased IgM in some, normal B cells, low switched memory B cells, Ig-class switch recombination and somatic hypermutation defectsFamily or personal history of cancer4. Isotype, light chain, or functional deficiencies with generally normal numbers of B cells Ig heavy chain mutations and deletions*Mutation or chromosomal deletion at 14q32*AROne or more IgG and/or IgA subclasses as well as IgE may be absentMay be asymptomatic Kappa chain deficiency*IGKC*AR147200All immunoglobulins have lambda light chainAsymptomatic Isolated IgG subclass deficiencyUnknown?Reduction in one or more IgG subclassUsually asymptomatic, a minority may have poor antibody response to specific antigens and recurrent viral/bacterial infections IgG subclass deficiency with IgA deficiencyUnknown?Reduced IgA with decrease in one or more IgG subclassRecurrent bacterial infections Selective IgA deficiencyUnknown?Very low to absent IgA with other isotypes normal, normal subclasses and specific antibodiesBacterial infections, autoimmunity mildly increased Specific antibody deficiency with normal Ig levels and normal B cellsUnknown?NormalReduced ability to produce antibodies to specific antigens Transient hypogammaglobulinemia of infancyUnknown?IgG and IgA decreasedNormal ability to produce antibodies to vaccine antigens, usually not associated with significant infections CARD11 GOF*CARD11*AD GOF607210High B cell numbers due to constitutive NF-κB activationSplenomegaly, lymphadenopathy, poor vaccine response Selective IgM deficiencyUnknown?Absent serum IgMPneumococcal / bacterial infectionsCommon variable immunodeficiency disorders (CVID) include several clinical and laboratory phenotypes that may be caused by distinct genetic and/or environmental factors. Some patients with CVID and no known genetic defect have markedly reduced numbers of B cells as well as hypogammaglobulinemia. Identification of causal variants can assist in defining treatment. In addition to monogenic causes on this table, a small minority of patients with XLP (Table [4](#Tab4){ref-type="table"}), WHIM syndrome (Table [6](#Tab6){ref-type="table"}), ICF (Table [2](#Tab2){ref-type="table"}), VOD1 (Table [2](#Tab2){ref-type="table"}), thymoma with immunodeficiency (Good syndrome) or myelodysplasia are first seen by an immunologist because of recurrent infections, hypogammaglobulinemia and normal or reduced numbers of B cells. Total number of disorders in Table [3](#Tab3){ref-type="table"}: 40. New disorders: 7, *PTEN*, *NFKB1*, *IKZF1*, *IRF2BP2*, *ATP6AP1.* Selective igA deficiency, selective IgM deficiency*EBV* Epstein-Barr virus, *COPD* chronic obstructive pulmonary disease, *XL* X-linked inheritance, *AR* autosomal recessive inheritance, *AD* autosomal dominant inheritance, *LOF* loss-of-function, *GOF* gain-of-function Table 4Diseases of immune dysregulationDiseaseGenetic defectInheritanceOMIMCirculating T cellsCirculating B cellsFunctional defectAssociated features1. Familial hemophagocytic lymphohistiocytosis (FHL syndromes)Perforin deficiency (FHL2)*PRF1*AR170280Increased activated T cellsNormalDecreased to absent NK and CTL activities cytotoxicityFever, (H)SM, hemophagocytic lymphohistiocytosis (HLH), cytopeniasUNC13D/Munc13-4 deficiency (FHL3)*UNC13D*AR608897Increased activated T cellsNormalDecreased to absent NK and CTL activities (cytotoxicity and/or degranulation)Fever, (H)SM, HLH, cytopenias,Syntaxin 11 deficiency (FHL4)*STX11*AR605014Increased activated T cellsNormalDecreased NK activity (cytotoxicity and/or degranulation)Fever, (H)SM, cHLH, cytopenias,STXBP2/Munc18-2 deficiency (FHL5)*STXBP2*AR or AD601717Increased activated T cellsNormalDecreased NK and CTL activities (cytotoxicity and/or degranulation)Fever, (H)SM, cHLH, cytopenias, enteropathyFAAP24 deficiency*FAAP24*AR610884Increased activated T cellsNormalFailure to kill autologous EBV transformed B cells. Normal NK cell functionEBV infection-driven lymphoproliferative disease2. FHL syndromes with hypopigmentationChediak-Higashi syndrome*LYST*AR606897Increased activated T cellsNormalDecreased NK and CTL activities (cytotoxicity and/or degranulation)Partial albinism, recurrent infections, fever, HSM, HLH, giant lysosomes, neutropenia, cytopenias, bleeding tendency, progressive neurological dysfunctionGriscelli syndrome, type 2*RAB27A*AR603868NormalNormalDecreased NK and CTL activities (cytotoxicity and/or degranulation)Partial albinism, fever, HSM, HLH, cytopeniasHermansky-Pudlak syndrome, type 2*AP3B1*AR603401NormalNormalDecreased NK and CTL activities (cytotoxicity and/or degranulation)Partial albinism, recurrent infections, pulmonary fibrosis, increased bleeding, neutropenia, HLHHermansky-Pudlak syndrome, type 10*AP3D1*AR617050NormalNormalDecreased NK and CTL activities (cytotoxicity and/or degranulation)Oculocutaneous albinism, severe neutropenia, recurrent infections, seizures, hearing loss, and neurodevelopmental delay3. Regulatory T cell defectsIPEX, immune dysregulation, polyendocrinopathy, enteropathy X-linked*FOXP3*XL300292NormalNormalLack of (and/or impaired function of) CD4^+^ CD25^+^ FOXP3^+^ regulatory T cells (Tregs)Autoimmune enteropathy, early-onset diabetes, thyroiditis hemolytic anemia, thrombocytopenia, eczema, elevated IgE, IgACD25 deficiency*IL2RA*AR147730Normal to decreasedNormalNo CD4 + C25+ cells with impaired function of Tregs cellsLymphoproliferation, autoimmunity, impaired T cell proliferationCTLA4 deficiency (ALPSV)*CTLA4*AD123890DecreasedDecreasedImpaired function of Tregs.Autoimmune cytopenias, enteropathy, interstitial lung disease, extra-lymphoid lymphocytic infiltration recurrent infectionsLRBA deficiency*LRBA*AR606453Normal or decreased CD4 numbers, T cell dysregulationLow or normal numbers of B cellsReduced I IgG and IgA in mostRecurrent infections, inflammatory bowel disease, autoimmunity, EBV infectionsSTAT3 GOF mutation*STAT3*AD (GOF)102582DecreasedDecreasedEnhanced STAT3 signaling, leading to increased Th17 cell differentiation, lymphoproliferation and autoimmunity. Decreased Tregs and impaired functionLymphoproliferation, solid organ autoimmunity, recurrent infectionsBACH2 deficiency*BACH2*AD605394Progressive T cell lymphopeniaImpaired memory B cell developmentHaplosufficiency for a critical lineage specification transcription factorLymphocytic colitis, sinopulmonary infections4. Autoimmunity with or without LymphoproliferationAPECED (APS-1), autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy*AIRE*AR or AD607358NormalNormalAIRE serves as check-point in the thymus for negative selection of autoreactive T cells and for generation of TregsAutoimmunity: hypoparathyroidism hypothyroidism, adrenal insufficiency, diabetes, gonadal dysfunction and other endocrine abnormalities, chronic mucocutaneous candidiasis, dental enamel hypoplasia, alopecia areata enteropathy, pernicious anemiaITCH deficiency*ITCH*AR606409Not assessedNot assessedItch deficiency may cause immune dysregulation by affecting both anergy induction in autoreactive effector T cells and generation of TregsEarly-onset chronic lung disease (interstitial pneumonitis), autoimmunity (thyroiditis, type I diabetes, chronic diarrhea/enteropathy, and hepatitis), failure to thrive, developmental delay, dysmorphic facial featuresZAP-70 combined hypomorphic and activation mutations*ZAP70*AR (LOF/GOF)176947Decreased CD8, normal or decreased CD4 cellsNormal or decreasedHyperactive Zap70 kinaseSevere autoimmunityTripeptidyl-peptidase II deficiency*TPP2*AR190470DecreasedDecreasedTPP2 deficiency results in premature immunosenescence and immune dysregulationVariable lymphoproliferation, severe autoimmune cytopenias, hypergammaglobulinemia, recurrent infectionsJAK1 GOF*JAK1*AD GOF147795Not assessedNot assessedHyperactive JAK1HSM, eosinophilia, eosinophilic enteritis, thyroid disease, poor growth, viral infectionsProlidase deficiency*PEPD*AR613230NormalNormalPeptidase DAutoantibodies common, chronic skin ulcers, eczema, infections5. Autoimmune lymphoproliferative syndrome (ALPS, Canale-Smith syndrome)ALPS-FAS*TNFRSF6*AD or AR134637Increased CD4^−^CD8^−^TCR α/β-double negative (DN) T cellsNormal, low memory B cellsApoptosis defect FAS mediatedSplenomegaly, adenopathies, autoimmune cytopenias, increased lymphoma risk, IgG and A normal or increased, elevated serum FasL and IL-10, vitamin B~12~ALPS-FASLG*FASLG*AR134638Increased DN T cellsNormalApoptosis defect FAS mediatedSplenomegaly, adenopathies, autoimmune cytopenias, SLE, soluble FasL is not elevatedALPS-caspase 10*CASP10*AD601762Increased DN T cellsNormalDefective lymphocyte apoptosisAdenopathies, splenomegaly, autoimmunityALPS-caspase 8*CASP8*AR601763Slightly increased DN T cellsNormalDefective lymphocyte apoptosis and activationAdenopathies, splenomegaly, bacterial and viral infections, hypogammaglobulinemiaFADD deficiency*FADD*AR602457Increased DN T cellsNormalDefective lymphocyte apoptosisFunctional hyposplenism, bacterial and viral infections, recurrent episodes of encephalopathy and liver dysfunction6. Immune dysregulation with colitisIL-10 deficiency*IL10*AR124092NormalNormalNo functional IL-10 secretionInflammatory bowel disease (IBD), Folliculitis, recurrent respiratory diseases, arthritis,IL-10Ra deficiency*IL10RA*AR146933NormalNormalLeukocytes unresponsive to IL-10IBD, Folliculitis, recurrent respiratory diseases, arthritis, lymphomaIL-10Rb deficiency*IL10RB*AR123889NormalNormalLeukocytes unresponsive to IL-10, IL-22, IL-26, IL-28A, IL-28B, and IL-29IBD, folliculitis, recurrent respiratory diseases, arthritis, lymphomaNFAT5 haploinsufficiency*NFAT5*AD604708NormalNormalDecreased memory B cells and plasmablastsIBD, recurrent sinopulmonary infections7. Susceptibility to EBV and lymphoproliferative conditionsSH2D1A deficiency (XLP1)*SH2D1A*XL300490Normal or increased activated T cellsReduced memory B cellsnormal NK cell and CTL cytotoxic activityClinical and immunologic features triggered by EBV infection: HLH, lymphoproliferation, aplastic anemia, lymphoma. hypogammaglobulinemia, absent iNKT cellsXIAP deficiency (XLP2)*XIAP*XL300079Normal or Increased activated T cells; low/normal iNKT cellsNormal or reduced memory B cellsIncreased T cells susceptibility to apoptosis to CD95 and enhanced activation-induced cell death (AICD)EBV infection, splenomegaly, lymphoproliferation HLH, colitis, IBD, hepatitis low iNKT cells, hypogammaglobulinemiaCD27 deficiency*CD27*AR615122NormalNo memory B cellsLow immunoglobulin after EBV infectionFeatures triggered by EBV infection, HLH, aplastic anemia, low iNKT cells, lymphomaCTPS1 deficiency*CTPS1*AR615897Nl to low, poor proliferation to antigenNl/lowNl/high IgGRecurrent/chronic bacterial and viral infections (EBV, VZV), lymphoproliferation, B cell non-Hodgkin lymphomaRASGRP1 deficiency*RASGRP1*AR603962Poor activation, proliferation, motilityPoor activation, proliferation, motilityNormal IgM, IgG, increased IgARecurrent pneumonia, herpesvirus infections, EBV associated lymphomaCD70 deficiency*CD70* (*TNFSF7*)AR602840Nl number, low Treg, poor activation and functionNl number, poor antibody and memory responsesReduced IgM, IgG, IgA (75%) and reduced Ag-specific Ab responses (50%)EBV susceptibility, Hodgkin lymphomaRLTPR (CARMIL2) deficiency*RLTPR*AR610859Nl number, low Treg, high CD4, poor functionNl numberNl to low, poor T dependent antibody responseRecurrent bacterial, fungal and mycobacterial infections, viral warts, molluscum and EBV lymphoproliferative and other malignancy, atopyITK deficiency*ITK*AR186973Progressive decreaseNormalNl to lowEBV associated B cell lymphoproliferation, lymphoma, Nl or low IgGMAGT1 deficiency (XMEN)*MAGT1*XL300853Low CD4\
Low recent thymic emigrant cells, poor proliferation to CD3NormalNormalEBV infection, lymphoma, viral infections, respiratory and GI infectionsPRKCD deficiency*PRKCD*AR176977NormalLow memory B cells, high CD5 B cellsApoptotic defect in B cellsRecurrent infections, EBV chronic infection, lymphoproliferation, SLE-like autoimmunity (nephrotic and antiphospholipid syndromes), low IgGTotal number of disorders in Table [4](#Tab4){ref-type="table"}: 40. New disorders: 9, *FAAP24*, *RASGRP1*, *CD70*, *RLTPR*, *ZAP70* (GOF + LOF), *AP3D1*, *BACH2*, *JAK1 GOF*, *PEPD*. Removed gene: Hermansky-Pudlak syndrome type 9 was removed due to retraction of the defining publication*FHL* familial hemophagocytic lymphohistiocytosis, *HLH* hemophagocytic lymphohistiocytosis, *HSM* hepatosplenomegaly ((H)SM indicating variable hepatomegaly), *DN* double negative, *SLE* systemic lupus erythematous, *IBD* inflammatory bowel disease, *XL* X-linked inheritance, *AR* autosomal recessive inheritance, *AD* autosomal dominant inheritance, *LOF* loss-of-function, *GOF* gain-of-function Table 5Congenital defects of phagocyte number or functionDiseaseGenetic defectInheritanceOMIMAffected cellsAffected functionAssociated features1. Congenital neutropenias Elastase deficiency (SCN1)*ELANE*AD130130NMyeloid differentiationSusceptibility to MDS/leukemia\
Severe congenital neutropenia or cyclic neutropenia GFI 1 deficiency (SCN2)*GFI1*AD600871NMyeloid differentiationB/T lymphopenia HAX1 deficiency (Kostmann disease) (SCN3)*HAX1*AR605998NMyeloid differentiationCognitive and neurological defects in patients with defects in both HAX1 isoforms, susceptibility to MDS/leukemia G6PC3 deficiency (SCN4)*G6PC3*AR611045NMyeloid differentiation, chemotaxis, O~2~ ^−^ productionStructural heart defects, urogenital abnormalities, inner ear deafness, and venous angiectasias of trunks and limbs VPS45 deficiency (SCN5)*VPS45*AR610035NMyeloid differentiation, migrationExtramedullary hematopoiesis, bone marrow fibrosis, nephromegaly Glycogen storage disease type 1b*G6PT1*AR602671N + MMyeloid differentiation, chemotaxis, O~2~ ^−^ productionFasting hypoglycemia, lactic acidosis, hyperlipidemia, hepatomegaly X-linked neutropenia/myelodysplasia WAS GOF*WAS*XL300392NDifferentiation, mitosisNeutropenia, myeloid maturation arrest, monocytopenia, variable lymphoid anomalies P14/LAMTOR2 deficiency*LAMTOR2*AR610389N + MEndosomal biogenesisNeutropenia\
Hypogammaglobulinemia ↓CD8 cytotoxicity, partial albinism, growth failure Barth syndrome (3-methylglutaconic aciduria type II)*TAZ*XL300394N + L MelMitochondrial functionCardiomyopathy, myopathy, growth retardation, neutropenia Cohen syndrome*VPS13B*AR607817NMyeloid differentiationDysmorphism, mental retardation, obesity, deafness, neutropenia Clericuzio syndrome (poikiloderma with neutropenia)*USB1*AR613276NMyeloid differentiationRetinopathy, developmental delay, facial dysmorphisms, poikiloderma JAGN1 deficiency*JAGN1*AR616012NMyeloid differentiationMyeloid maturation arrest, osteopenia 3-Methylglutaconic aciduria*CLPB*AR616254NMyeloid differentiation\
Mitochondrial proteinNeurocognitive developmental aberrations, microcephaly, hypoglycemia, hypotonia, ataxia, seizures, cataracts, IUGR G-CSF receptor deficiency*CSF3R*AR138971NStress granulopoiesis disturbed SMARCD2 deficiency*SMARCD2*AR601736NChromatin remodeling, myeloid differentiation and neutrophil functional defectNeutropenia, developmental aberrations, skeletal abnormalities, hematopoietic stem cells, myelodysplasia HYOU1 deficiency*HYOU1*AR601746NUnfolded protein responseHypoglycemia, inflammatory complications2. Defects of motility Leukocyte adhesion deficiency type 1 (LAD1)*ITGB2*AR600065N + M +L + NKAdherence, chemotaxis, endocytosis, T/NK cytotoxicityDelayed cord separation, skin ulcers, periodontitis, leukocytosis Leukocyte adhesion deficiency type 2 (LAD2)*SLC35C1*AR605881N + MRolling, chemotaxisMild LAD type 1 features with hh-blood group, growth retardation, developmental delay Leukocyte adhesion deficiency type 3 (LAD3)*FERMT3*AR607901N + M + L + NKAdherence, chemotaxisLAD type 1 plus bleeding tendency Rac 2 deficiency*RAC2*AD602049NAdherence, chemotaxis O~2~ ^−^ productionPoor wound healing, leukocytosis β actin deficiency*ACTB*AD102630N + MMotilityMental retardation, short stature Localized juvenile periodontitis*FPR1*AR136537NFormylpeptide induced chemotaxisPeriodontitis only Papillon-Lefèvre syndrome*CTSC*AR602365N + MChemotaxisPeriodontitis, palmoplantar hyperkeratosis in some patients Specific granule deficiency*CEBPE*AR189965NChemotaxisNeutrophils with bilobed nuclei Shwachman-Diamond syndrome*SBDS*AR607444NChemotaxisPancytopenia, exocrine pancreatic insufficiency, chondrodysplasia WDR1 deficiency*WDR1*AR604734NSpreading, survival, chemotaxisMild neutropenia, poor wound healing, severe stomatitis, neutrophil nuclei herniate Cystic fibrosis*CFTR*AR602421M onlyChemotaxisRespiratory infections, pancreatic insufficiency, elevated sweat chloride Schwachman Diamond syndrome due to DNAJC21 deficiency*DNAJC21*AR617048NMotility, ribosome biogenesisMetaphyseal changes, short stature, developmental delay, pancreatic dysfunction, bone marrow failure Neutropenia with combined immune deficiency due to MKL1 deficiency*MKL1*AR606078N + M +L + NKImpaired expression of cytoskeletal genesMild thrombocytopenia3. Defects of respiratory burst X-linked chronic granulomatous disease (CGD), gp91phox*CYBB*XL300481N + MKilling (faulty O~2~ ^−^ production)Infections, autoinflammatory phenotype, IBD\
McLeod phenotype in patients with deletions extending into the contiguous Kell locus Autosomal recessive CGD p22phox*CYBA*AR608508N + MKilling (faulty O~2~ ^−^ production)Infections, autoinflammatory phenotype Autosomal recessive CGD p47phox*NCF1*AR608,512N + MKilling (faulty O~2~ ^−^ production)Infections, autoinflammatory phenotype Autosomal recessive CGD p67phox*NCF2*AR608515N + MKilling (faulty O~2~ ^−^ production)Infections, autoinflammatory phenotype Autosomal recessive CGD p40phox*NCF4*AR601488N + MKilling (faulty O~2~ ^−^ production)Infections, autoinflammatory phenotype G6PD deficiency class I*G6PD*XL305900NReduced O~2~ ^−^ productionInfections4. Other non-lymphoid defects GATA2 deficiency (MonoMac syndrome)*GATA2: loss of stem cells*AD137295Monocytes + peripheral DCMulti lineage cytopeniasSusceptibility to mycobacteria, HPV, histoplasmosis, alveolar proteinosis, MDS/AML/CMMoL, lymphedema Congenital pulmonary alveolar proteinosis due to CSF2RB mutations*CSF2RB*AR138981Alveolar macrophagesGM-CSF signalingAlveolar proteinosis Congenital pulmonary alveolar proteinosis due to CSF2RA mutations*CSF2RA*XL (pseudoautosomal)306250Alveolar macrophagesGM-CSF signalingAlveolar proteinosisTotal number of disorders in Table [5](#Tab5){ref-type="table"}: 39. New disorders: 9, *WDR1*, *CFTR*, *SMARCD2*, *JAGN1*, *HYOU1*, *MKL1*, *DNAJC21*, *G6PD*, *CSF2RB*. Removed: cyclic neutropenia was merged with elastase deficiency*MDS* myelodysplastic syndrome, *IUGR* intrauterine growth retardation, *LAD* leukocyte adhesion deficiency, *AML* acute myelogenous leukemia, *CMML* chronic myelomonocytic leukemia, *N* neutrophil, *M* monocyte, *MEL* melanocyte, *L* lymphocyte, *NK* natural killer, *XL* X-linked inheritance, *AR* autosomal recessive inheritance, *AD* autosomal dominant inheritance, *GOF* gain-of-function Table 6Defects in intrinsic and innate immunityDiseaseGenetic defectInheritanceOMIMAffected cellsAffected functionAssociated features1. Mendelian susceptibility to mycobacterial disease (MSMD) IL-12 and IL-23 receptor β1 chain deficiency*IL12RB1*AR601604L + NKIFN-γ secretionSusceptibility to mycobacteria and *Salmonella* IL-12p40 (IL-12 and IL-23) deficiency*IL12B*AR161561MIFN-γ secretionSusceptibility to mycobacteria and *Salmonella* IFN-γ receptor 1 deficiency*IFNGR1*AR/AD107470M + LIFN-γ binding and signalingSusceptibility to mycobacteria and *Salmonella* IFN-γ receptor 2 deficiency*IFNGR2*AR147569M + LIFN-γ signalingSusceptibility to mycobacteria and *Salmonella* STAT1 deficiency (AD LOF)*STAT1*AD600555M + LIFN-γsignalingSusceptibility to mycobacteria, *Salmonella* Macrophage gp91 phox deficiency*CYBB*XL300481Macrophage onlyKilling (faulty O~2~ ^−^ production)Isolated susceptibility to mycobacteria IRF8 deficiency (AD)*IRF8*AD601565CD1c+ MDCDifferentiation of CD1c+ MDC subgroupSusceptibility to mycobacteria IRF8 deficiency (AR)*IRF8*AR601565CD1c+ MDCDifferentiation of CD1c+ MDC subgroupSusceptibility to mycobacteria and multiple other infectious agents Tyk2 deficiency*TYK2*AR176941Normal, but multiple cytokine signaling defectNormalSusceptibility to intracellular bacteria (mycobacteria, Salmonella), viruses, +/− elevated IgE ISG15 deficiency*ISG15*AR147571IFNγ production defectSusceptibility to mycobacteria (BCG), brain calcification RORc deficiency*RORC*AR602943L + NKLack of functional RORγT protein, IFNγ production defect, complete absence of IL-17A/F-producing T cellsSusceptibility to mycobacteria and candida JAK1 (LOF)*JAK1*AR147795N + LIFNγ productionSusceptibility to mycobacteria and viruses, urothelial carcinoma2. Epidermodysplasia verruciformis (HPV) EVER1 deficiency*TMC6*AR605828Keratinocytes and leukocytesEVER proteins may be involved in the regulation of cellular zinc homeostasis in lymphocytesHuman papillomavirus (HPV) (group B1) infections and cancer of the skin (typical EV) EVER2 deficiency*TMC8*AR605829Keratinocytes and leukocytesEVER proteins may be involved in the regulation of cellular zinc homeostasis in LyHPV (group B1) infections and cancer of the skin (typical EV) WHIM (warts, hypogammaglobulinemia, infections, myelokathexis) syndrome*CXCR4*AD GOF162643Granulocytes + lymphocytesIncreased response of the CXCR4 chemokine receptor to its ligand CXCL12 (SDF-1)Warts, neutropenia, low B cell number, hypogammaglobulinemia3. Predisposition to severe viral infection STAT1 deficiency (AR LOF)*STAT1*AR600555T and NK cells and monocytesSTAT1-dependent IFN-α, β, and γ responseSevere viral infections, mycobacterial infection STAT2 deficiency*STAT2*AR600556T and NK cellsSTAT2-dependent IFN-α, β, and γ responseSevere viral infections (disseminated vaccine-strain measles) IRF7 deficiency*IRF7*AR605047Leukocytes, plasmacytoid dendritic cells, non-hematopoietic cellsIFN-α, β, and γ production and IFN-λ productionSevere influenza disease IFNAR2 deficiency*IFNAR2*AR602376Broadly expressedNo response to IFN-αSevere viral infections (disseminated vaccine-strain measles, HHV6) CD16 deficiency*FCGR3A*AR146740NK cellsAltered NK cells functionSevere herpes viral infections, particularly VZV, Epstein-Barr virus (EBV), and (HPV) MDA5 deficiency (LOF)*IFIH1*AR606951Somatic and hematopoieticViral recognitionRhinovirus and other RNA viruses4. Herpes simplex encephalitis (HSE) TLR3 deficiency*TLR3*AD or AR603029Central nervous system (CNS) resident cells and fibroblastsTLR3-dependent IFN-α, β, and γ responseHerpes simplex virus 1 encephalitis (incomplete clinical penetrance for all etiologies listed here) UNC93B1 deficiency*UNC93B1*AR608204CNS resident cells and fibroblastsUNC-93B-dependent IFN-α, β, and γ responseHerpes simplex virus 1 encephalitis TRAF3 deficiency*TRAF3*AD601896CNS resident cells and fibroblastsTRAF3-dependent IFN-α, β, and γ responseHerpes simplex virus 1 encephalitis TRIF deficiency*TICAM1*AD or AR607601CNS resident cells and fibroblastsTRIF-dependent IFN-α, β, and γ responseHerpes simplex virus 1 encephalitis TBK1 deficiency*TBK1*AD604834CNS resident cells and fibroblastsTBK1-dependent IFN-α, β, and γ responseHerpes simplex virus 1 encephalitis IRF3 deficiency*IRF3*AD616532CNS resident cells and fibroblastsLow IFN-α/β production in response to HSV1 and decreased IRF3 phosphorylationHerpes simplex virus 1 encephalitis5. Predisposition to invasive fungal diseases CARD9 deficiency*CARD9*AR607212Mononuclear phagocytesCARD9 signaling pathwayInvasive candidiasis infection, deep dermatophytoses, other invasive fungal infections6. Predisposition to mucocutaneous candidiasis IL-17RA deficiency*IL17RA*AR605461Epithelial cells, fibroblasts, mononuclear phagocytesIL-17RA signaling pathwayCMC, folliculitis IL-17RC deficiency*IL17RC*AR610925Epithelial cells, fibroblasts, mononuclear phagocytesIL-17RC signaling pathwayCMC IL-17F deficiency*IL17F*AD606496T cellsIL-17F-containing dimersCMC, folliculitis STAT1 GOF*STAT1*AD GOF600555T cells, B cells, monocytesGain-of-function STAT1 mutations that impair the development of IL-17-producing T cellsCMC, various fungal, bacterial and viral (HSV) infections, autoimmunity (thyroiditis, diabetes, cytopenias), enteropathy ACT1 deficiency*TRAF3IP2*AR607043T cells, fibroblastsFibroblasts fail to respond to IL-17A and IL-17F, and their T cells to IL-17ECMC, blepharitis, folliculitis and macroglossia7. TLR signaling pathway deficiency with bacterial susceptibility IRAK-4 deficiency*IRAK4*AR606883Lymphocytes + granulocytes + monocytesTIR-IRAK4 signaling pathwayBacterial infections (pyogens) MyD88 deficiency*MYD88*AR602170Lymphocytes + granulocytes + monocytesTIR-MyD88 signaling pathwayBacterial infections (pyogens) IRAK1 deficiency*IRAK1*XLNot yet attributedLymphocytes + granulocytes + monocytesTIR-IRAK1 signaling pathwayBacterial infections, X-linked MECP2 deficiency-related syndrome due to a large de novo Xq28 chromosomal deletion encompassing both *MECP2* and *IRAK1* TIRAP deficiency*TIRAP*AR614382Lymphocytes + granulocytes+ monocytesTIRAP- signaling pathway, TLR1/2, TLR2/6, and TLR4 agonists were impaired in the fibroblasts and leukocytesStaphylococcal disease during childhood8. Other inborn errors of immunity related to non-hematopoietic tissues Isolated congenital asplenia (ICA) due to RPSA deficiency*RPSA*AD271400No spleenRPSA encodes ribosomal protein SA, a component of the small subunit of the ribosomeBacteremia (encapsulated bacteria) Isolated congenital asplenia (ICA) due to HMOX deficiency*HMOX*AR141250MacrophagesHO-1 regulates iron recycling and heme-dependent damage occursHemolysis, nephritis, inflammation Trypanosomiasis*APOL1*AD603743SomaticLipidTrypanosomiasis Acute liver failure due to NBAS deficiency*NBAS*AR608025Somatic and hematopoieticER stressFever induces liver failure Acute necrotizing encephalopathy*RANBP2*AD601181Ubiquitous expressionNuclear poreFever induces acute encephalopathy CLCN7 deficiency associated osteopetrosis*CLCN7*AR602727OsteoclastsSecretory lysosomesOsteopetrosis with hypocalcemia, neurologic features SNX10 deficiency associated osteopetrosis*SNX10*AR614780OsteoclastsSecretory lysosomesOsteopetrosis with visual impairment OSTM1 deficiency associated osteopetrosis*OSTM1*AR607649OsteoclastsSecretory lysosomesOsteopetrosis with hypocalcemia, neurologic features PLEKHM1 deficiency associated osteopetrosis*PLEKHM1*AR611466OsteoclastsSecretory lysosomesOsteopetrosis TCIRG1 deficiency associated osteopetrosis*TCIRG1*AR604592OsteoclastsSecretory lysosomesOsteopetrosis with hypocalcemia TNFRSF11A deficiency associated osteopetrosis*TNFRSF11A*AR603499OsteoclastsOsteoclastogenesisOsteopetrosis TNFSF11 deficiency associated osteopetrosis*TNFSF11*AR602642StromalOsteoclastogenesisOsteopetrosis with severe growth retardationNCSTN deficiency hidradenitis suppurativa*NCSTN*AD605254EpidermisGamma-secretase in hair follicle regulates keratinizationHidradenitis suppurativa with acne PSEN deficiency hidradenitis suppurativa*PSEN*AD104311EpidermisGamma-secretase in hair follicle regulates keratinizationHidradenitis suppurative with cutaneous hyperpigmentation PSENEN deficiency hidradenitis suppurativa*PSENEN*AD607632EpidermisGamma-secretase in hair follicle regulates keratinizationHidradenitis suppurativaTotal number of disorders in Table [6](#Tab6){ref-type="table"}: 52. New genes: 19, *IFNAR* ***2***, *IRF3*, *JAK1*, *IRAK1*, *TIRAP*, *IFIH1*, *HMOX*, *NBAS*, *RANBP2*, *CLCN7*, *SNX10*, *OSTM1*, *PLEKHM1*, *TCIRG1*, *TNFRSF11A*, *TNFSF11*, *NCSTN*, *PSEN*, *PSENENNF-κB* nuclear factor kappa B, *TIR* Toll and interleukin-1 receptor, *IFN* interferon, *TLR* Toll-like receptor, *MDC* myeloid dendritic cell, *CNS* central nervous system, *CMC* chronic mucocutaneous candidiasis, *HPV* human papillomavirus, *VZV* varicella zoster virus, *EBV* Epstein-Barr virus, *HHV6* human herpesvirus 6, *XL* X-linked inheritance, *AR* autosomal recessive inheritance, *AD* autosomal dominant inheritance, *LOF* loss-of-function, *GOF* gain-of-function Table 7Autoinflammatory disorders1. Type 1 interferonopathiesDiseaseGenetic defectInheritanceOMIMT cellsB cellsFunctional defectAssociated featuresTREX1 deficiency, Aicardi-Goutieres syndrome 1 (AGS1)*TREX1*AR or AD606609Not assessedNot assessedIntracellular accumulation of abnormal ss DNA species leading to increased type I IFN productionClassical AGS, SLE, FCLRNASEH2B deficiency, AGS2*RNASEH2B*AR610326Not assessedNot assessedIntracellular accumulation of abnormal RNA-DNA hybrid species leading to increased type I IFN productionClassical AGS, SPRNASEH2C deficiency, AGS3*RNASEH2C*AR610330Not assessedNot assessedIntracellular accumulation of abnormal RNA-DNA hybrid species leading to increased type I IFN productionClassical AGSRNASEH2A deficiency, AGS4*RNASEH2A*AR606034Not assessedNot assessedIntracellular accumulation of abnormal RNA-DNA hybrid species leading to increased type I IFN productionClassical AGSSAMHD1 deficiency, AGS5*SAMHD1*AR606754Not assessedNot assessedControls dNTPs in the cytosol, failure of which leads to increased type I IFN productionClassical AGS, FCLADAR1 deficiency, AGS6*ADAR1*AR146920Not assessedNot assessedCatalyzes the deamination of adenosine to inosine in dsRNA substrates, failure of which leads to increased type I IFN productionClassical AGS, BSN, SPAicardi-Goutieres syndrome 7 (AGS7)*IFIH1* (GOF)AD606951Not assessedNot assessedIFIH1 gene encodes a cytoplasmic viral RNA receptor that activates type I interferon signaling through the MAVS adaptor moleculeClassical AGS, SLE, SP, SMSSpondyloenchondro-dysplasia with immune dysregulation (SPENCD)*ACP5*AR171640Not assessedNot assessedUpregulation of IFN through mechanism possibly relating to pDCSShort stature, SP, ICC, SLE, thrombocytopenia and autoimmune hemolytic anemia, possibly recurrent bacterial and viral infectionsSTING-associated vasculopathy, infantile-onset*TMEM173*AR612374Not assessedNot assessedSTING activates both the NF-kappa-B and IRF3 transcription pathways to induce expression of IFNSkin vasculopathy, inflammatory lung disease, systemic autoinflammation and ICC, FCLX-linked reticulate pigmentary disorder*POLA1*XL301220Not assessedNot assessedPOLA1 is required for synthesis of cytosolic RNA:DNA and its deficiency leads to increase production of type I interferonHyperpigmentation, characteristic facies, lung and GI involvementUSP18 deficiency*USP18*AR607057Not assessedNot assessedDefective negative regulation of ISG15 leading to increased IFNTORCH like syndromeCANDLE (chronic atypical neutrophilic dermatitis with lipodystrophy)*PSMB8* ^a^AR and AD256040Not assessedNot assessedMutations cause increased IFN signaling through an undefined mechanismContractures, panniculitis, ICC, feversSingleton-Merten syndrome*DDX58*AD609631Not assessedNot assessedRecognizes double stranded RNADental dysplasia), calcifications in the aorta, osteoporosis, especially in the hands and feet2. Defects affecting the inflammasomeDiseaseGenetic defectInheritanceOMIMAffected cellsFunctional defectsAssociated featuresFamilial Mediterranean feverMEFVAR or AD249100\
134610Mature granulocytes, cytokine-activated monocytesDecreased production of pyrin permits ASC-induced IL-1 processing and inflammation following subclinical serosal injury, macrophage apoptosis decreasedRecurrent fever, serositis and inflammation responsive to colchicine. Predisposes to vasculitis and inflammatory bowel diseaseMevalonate kinase deficiency (Hyper IgD syndrome)MVKAR260920Somatic and hemaotpoieticAffecting cholesterol synthesis, pathogenesis of disease unclearPeriodic fever and leukocytosis with high IgD levelsMuckle-Wells syndromeNLRP3 (also called NALP3 CIAS1 or PYPAF1)AD GOF191900PMNs MonocytesDefect in cryopyrin, involved in leukocyte apoptosis and NFkB signaling and IL-1 processingUrticaria, SNHL, amyloidosisFamilial cold autoinflammatory syndrome 1NLRP3AD GOF120100PMNs, monocytesAs aboveNon-pruritic urticaria, arthritis, chills, fever and leukocytosis after cold exposureFamilial cold autoinflammatory syndrome 2NLRP12AD GOF611762PMNs, monocytesAs aboveNon-pruritic urticaria, arthritis, chills, fever and leukocytosis after cold exposureNeonatal onset multisystem inflammatory disease (NOMID) or chronic infantile neurologic cutaneous and articular syndrome (CINCA)NLRP3AD GOF607115PMNs, chondrocytesAs aboveNeonatal onset rash, chronic meningitis, and arthropathy with fever and inflammationNLRC4-MAS (macrophage activating syndrome) or familial cold autoinflammatory syndrome 4NLRC4AD GOF616050\
616115PMNs monocytes macrophagesGain-of-function mutation in NLRC4 results in elevated secretion of IL-1β and IL-18 as well as macrophage activationSevere enterocolitis and macrophage activation syndromePLAID (PLCγ2 associated antibody deficiency and immune dysregulation) or familial cold autoinflammatory syndrome 3 or APLAID (c2120A\>C)*PLCG2*AD GOF614468B cells, NK, mast cellsMutations cause activation of IL-1 pathwaysCold urticaria hypogammaglobulinemia, autoinflammationNLRP1 deficiencyNLRP1AR606579LeukocytesSystemic elevation of IL-18 and caspase 1, suggesting involvement of NLRP1 inflammasomeDyskeratosis, autoimmunity and arthritis3. Non-inflammasome-related conditionsDiseaseGenetic defectInheritanceOMIMAffected cellsFunctional defectsAssociated FeaturesTNF receptor-associated periodic syndrome (TRAPS)*TNFRSF1A*AD142680PMNs, monocytesMutations of 55-kD TNF receptor leading to intracellular receptor retention or diminished soluble cytokine receptor available to bind TNFRecurrent fever, serositis, rash, and ocular or joint inflammationPyogenic sterile arthritis, pyoderma gangrenosum, acne (PAPA) syndrome, hyperzincemia, and hypercalprotectinemia*PSTPIP1* (also called *C2BP1*)AD604416Hematopoietic tissues, upregulated in activated T cellsDisordered actin reorganization leading to compromised physiologic signaling during inflammatory responseDestructive arthritis, inflammatory skin rash, myositisBlau syndrome*NOD2* (also called CARD15)AD186580MonocytesMutations in nucleotide binding site of CARD15, possibly disrupting interactions with lipopolysaccharides and NF-kB signalingUveitis, granulomatous synovitis, camptodactyly, rash and cranial neuropathies, 30% develop Crohn colitisADAM17 deficiency*ADAM17*AR614328Leukocytes and epithelial cellsDefective TNFα productionEarly-onset diarrhea and skin lesionsChronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anemia (Majeed syndrome)*LPIN2*AR609628Neutrophils, bone marrow cellsUndefinedChronic recurrent multifocal osteomyelitis, transfusion-dependent anemia, cutaneous inflammatory disordersDIRA (deficiency of the interleukin-1 receptor antagonist)*IL1RN*AR612852PMNs, MonocytesMutations in the IL-1 receptor antagonist allow unopposed action of interleukin-1Neonatal onset of sterile multifocal osteomyelitis, periostitis and pustulosisDITRA (deficiency of IL-36 receptor antagonist)*IL36RN*AR614204Keratinocytes, leukocytesMutations in IL-36RN leads to increase IL-8 productionPustular psoriasisSLC29A3 mutation*SLC29A3*AR602782Leukocytes, bone cellsHyperpigmentation hypertrichosis, histiocytosis-lymphadenopathy plus syndromeCAMPS (CARD14 mediated psoriasis)*CARD14*AD602723Mainly in keratinocytesMutations in CARD14 activate the NF-kB pathway and production of IL-8PsoriasisCherubism*SH3BP2*AD118400Stroma cells, bone cellsHyperactived macrophage and increase NF-kBBone degeneration in jawsCOPA defect*COPA*AD6011924PMN and tissue specific cellsDefective intracellular transport via the coat protein complex I (COPI)Autoimmune inflammatory arthritis and interstitial lung disease with Th17 dysregulation and autoantibody productionOtulipenia/ORAS*OTULIN*AR615712LeukocytesIncrease LUBAC induction of NF-KB activation leading to high proinflammatory cytokines levelsFever, diarrhea, dermatitisA20 deficiency*TNFAIP3*AD LOF616744LymphocytesDefective inhibition of NF-KB signaling pathwayArthralgia, mucosal ulcers, ocular inflammationADA2 deficiency*CECR1*AR607575LymphocytesADAs deactivate extracellular adenosine and terminate signaling through adenosine receptorsPolyarteritis nodosa, childhood-onset, early-onset recurrent ischemic stroke and feverAP1S3 deficiency*AP1S3*AR615781KeratinocytesDisrupted TLR3 translocationPustular psoriasisTotal number of disorders in Table [7](#Tab7){ref-type="table"}: 37. New disorders: 7, *DDX58*, *POLA1*, *USP18*, *NLRP1*, *OTULIN*, *TNFAIP3*, *AP1S3IFN* interferon; *HSM* hepatosplenomegaly; *CSF* cerebrospinal fluid; *SLE* systemic lupus erythematosus; *TORCH* toxoplasmosis, other, rubella, cytomegalovirus, and herpes infections; *SNHL* sensorineural hearing loss; *AGS* Aicardi-Goutières syndrome; *BSN* bilateral striatal necrosis; *FCL* familial chilblain lupus; *ICC* intracranial calcification; *IFN* interferon type I; *pDCs* plasmacytoid dendritic cells; *SP* spastic paraparesis; *SMS* Singleton-Merten syndrome; *ss* single-stranded DNA; *XL* X-linked inheritance; *AR* autosomal recessive inheritance; *AD* autosomal dominant inheritance; *LOF* loss-of-function; *GOF* gain-of-function^a^Variants in *PSMB4*, *PSMB9*, *PSMA3*, and *POMP* have been proposed to cause a similar CANDLE phenotype in monogenic and digenic models Table 8Complement deficiencies1. Complement deficienciesDiseaseGenetic defectInheritanceGene OMIMLaboratory featuresAssociated featuresC1q deficiency due to defects in C1QA*C1QA*AR120550Absent CH50 hemolytic activity, defective activation of the classical pathway, diminished clearance of apoptotic cellsSLE, infections with encapsulated organismsC1q deficiency due to defects in C1QB*C1QB*AR120570Absent CH50 hemolytic activity, Defective activation of the classical pathway, diminished clearance of apoptotic cellsSLE, infections with encapsulated organismsC1q deficiency due to defects in C1QC*C1QC*AR120575Absent CH50 hemolytic activity, Defective activation of the classical pathway, diminished clearance of apoptotic cellsSLE, infections with encapsulated organismsC1r deficiency*C1R*AR613785Absent CH50 hemolytic activity, defective activation of the classical pathwaySLE, infections with encapsulated organisms, Ehlers-Danlos phenotypeC1s deficiency*C1S*AR120580Absent CH50 hemolytic activity, defective activation of the classical pathwaySLE, infections with encapsulated organisms, Ehlers-Danlos phenotypeComplete C4 deficiency*C4A + C4B*AR120810Absent CH50 hemolytic activity, defective activation of the classical pathway, complete deficiency requires biallelic mutations/deletions/conversions of both C4A and C4BSLE, infections with encapsulated organisms, partial deficiency is common (either C4A or C4B) and appears to have a modest effect on host defenseC2 deficiency*C2*AR217000Absent CH50 hemolytic activity, defective activation of the classical pathwaySLE, infections with encapsulated organisms, atherosclerosisC3 deficiency (LOF)*C3*AR120700Absent CH50 and AH50 hemolytic activity, defective opsonization, defective humoral immune responseInfections, glomerulonephritis, atypical hemolytic-uremic syndrome with GOF mutationsC3 GOF*C3*AD120700Increased activation of complementAtypical hemolytic-uremic syndromeC5 deficiency*C5*AR120900Absent CH50 and AH50 hemolytic activity Defective bactericidal activityDisseminated neisserial infectionsC6 deficiency*C6*AR217050Absent CH50 and AH50 hemolytic activity, defective bactericidal activityDisseminated neisserial infectionsC7 deficiency*C7*AR217070Absent CH50 and AH50 hemolytic activity, defective bactericidal activityDisseminated neisserial infectionsC8α deficiency*C8A*AR120950Absent CH50 and AH50 hemolytic activity, defective bactericidal activityDisseminated neisserial infectionsC8γ deficiency*C8G*AR120930Absent CH50 and AH50 hemolytic activity, defective bactericidal activityDisseminated neisserial infectionsC8β-deficiency*C8B:*AR120960Absent CH50 and AH50 hemolytic activity, defective bactericidal activityDisseminated neisserial infectionsC9 deficiency*C9*AR120940Reduced CH50 and AP50 hemolytic activity, deficient bactericidal activityMild susceptibility to disseminated neisserial infectionsMASP2 deficiency*MASP2*AR605102Deficient activation of the lectin activation pathwayPyogenic infections, inflammatory lung disease, autoimmunityFicolin 3 deficiency*FCN3*AR604973Absence of complement activation by the Ficolin 3 pathway.Respiratory infections, abscessesC1 inhibitor deficiency*SERPING1*AD606860Spontaneous activation of the complement pathway with consumption of C4/C2, spontaneous activation of the contact system with generation of bradykinin from high molecular weight kininogenHereditary angioedemaFactor B GOF*CFB*AD138470Gain-of-function mutation with increased spontaneous AH50Atypical hemolytic-uremic syndromeFactor B LOF*CFB*AR138470Deficient activation of the alternative pathwayInfections with encapsulated organismsFactor D deficiency*CFD*AR134350Absent AH50 hemolytic activityNeisserial infectionsProperdin deficiency*CFP*XL300383Absent AH50 hemolytic activityNeisserial infectionsFactor I deficiency*CFI*AR217030Spontaneous activation of the alternative complement pathway with consumption of C3Infections, disseminated neisserial infections, atypical hemolytic-uremic syndrome, preeclampsiaFactor H deficiency*CFH*AR or AD134370Spontaneous activation of the alternative complement pathway with consumption of C3Infections, disseminated neisserial infections, atypical hemolytic-uremic syndrome, preeclampsiaFactor H-related protein deficiencies*CFHR1-5*AR or AD134371, 600889, 605336, 605337, 608593Normal CH50, AH50, autoantibodies to factor H, linked deletions of one or more CFHR genes leads to susceptibility autoantibody-mediated aHUSOlder onset atypical hemolytic-uremic syndrome, disseminated neisserial infectionsThrombomodulin deficiency*THBD*AD188040Normal CH50, AH50Atypical hemolytic-uremic syndromeMembrane cofactor protein (CD46) deficiency*CD46*AD120920Inhibitor of complement alternate pathway, decreased C3b bindingAtypical hemolytic-uremic syndrome, infections, preeclampsiaMembrane attack Complex inhibitor (CD59) deficiency*CD59*AR107271Erythrocytes highly susceptible to complement-mediated lysisHemolytic anemia, polyneuropathyCD55 deficiency (CHAPEL disease)*CD55*AR125240Hyperactivation of complement on endotheliumProtein losing enteropathy, thrombosisTotal number of disorders in Table [8](#Tab8){ref-type="table"}: 30. New disorders: 1, *CD55MAC* membrane attack complex, *SLE* systemic lupus erythematosus, *XL* X-linked inheritance, *AR* autosomal recessive inheritance, *AD* autosomal dominant inheritance, *LOF* loss-of-function, *GOF* gain-of-function Table 9Phenocopies of inborn errors of immunity1. Phenocopies of inborn errors of immunityDiseaseGenetic defect/presumed pathogenesisCirculating T cellsCirculating B cellsSerum IgAssociated features/similar PIDAssociated with somatic mutations Autoimmune lymphoproliferative syndrome (ALPS--SFAS)Somatic mutation in *TNFRSF6*Increased CD4−CD8− double negative (DN) T alpha/beta cellsNormal, but increased number of CD5+ B cellsNormal or increasedSplenomegaly, lymphadenopathy, autoimmune cytopenias, defective lymphocyte apoptosis/ALPS--FAS (=ALPS type Im) RAS-associated autoimmune leukoproliferative disease (RALD)Somatic mutation in *KRAS* (GOF)NormalB cell lymphocytosisNormal or increasedSplenomegaly, lymphadenopathy, autoimmune cytopenias, granulocytosis, monocytosis/ALPS-like RAS-associated autoimmune leukoproliferative disease (RALD)Somatic mutation in *NRAS* (GOF)Increased CD4−CD8− double negative (DN) T alpha/beta cellsLymphocytosisNormal or increasedSplenomegaly, lymphadenopathy, autoantibodies/ALPS-like Cryopyrinopathy, (Muckle-Wells/CINCA/NOMID-like syndrome)Somatic mutation in *NLRP3*NormalNormalNormalUrticaria-like rash, arthropathy, neurological signs Hypereosinophilic syndrome due to somatic mutations in STAT5bSomatic mutation in STAT5b (GOF)NormalNormalNormalEosinophilia, atopic dermatitis, urticarial rash, diarrhea Large granular lymphocytosisSomatic mutations in STAT3 (GOF)Clonal expansion of large T cellsNormalNormalAnemia, neutropenia, splenomegalyAssociated with autoantibodies Chronic mucocutaneous candidiasis (isolated or with APECED syndrome)Germline mutation in *AIRE* AutoAb to IL-17 and/or IL-22NormalNormalNormalEndocrinopathy, chronic mucocutaneous candidiasis/CMC Adult-onset immunodeficiency with susceptibility to mycobacteriaAutoAb to IFNγDecreased naive T cellsNormalNormalMycobacterial, fungal, *Salmonella* VZV infections/MSMD, or CID Recurrent skin infectionAutoAb to IL-6NormalNormalNormalStaphylococcal infections/STAT3 deficiency Pulmonary alveolar proteinosisAutoAb to GM-CSFNormalNormalNormalPulmonary alveolar proteinosis, cryptococcal meningitis, disseminated nocardiosis/CSF2RA deficiency Acquired angioedemaAutoAb to CI inhibitorNormalNormalNormalAngioedema/*C1 INH* deficiency (hereditary angioedema) Atypical hemolytic-uremic syndromeAutoAb to complement factor HNormalNormalNormalaHUS = spontaneous activation of the alternative complement pathway Thymoma with hypogammaglobulinemia (Good syndrome)AutoAb to various cytokinesIncreased CD8+ T cellsNo B cellsDecreasedInvasive bacterial, viral or opportunistic infections, autoimmunity, PRCA, lichen planus, cytopenia, colitis, chronic diarrheaTotal number of conditions for Table [9](#Tab9){ref-type="table"}: 12*aHUS* atypical hemolytic-uremic syndrome, *GOF* gain-of-function, *PRCA* pure red cell aplasia

The goal of the IUIS Expert Committee on Primary Immunodeficiencies is to increase awareness, facilitate recognition, promote optimal treatment, and support research in the field of immune deficiency disorders. Thus, the "IUIS PID Committee Report on Inborn Errors of Immunity" and "Update of the Phenotypical IUIS Classification for Primary Immunodeficiencies" publications are important resources for clinicians and researchers. In addition, these tables form the basis of lists used for sequencing panels and are used to monitor health utilization which will influence health services funding by federal or state governments and/or insurance companies in various global settings. The addition of ICD10 codes for the online version will promote a harmonization between the diagnostic tables and coding items that will facilitate bioinformatics research going forward.
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